Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

UV light helped human hair transplants survive in mice without broad immunosuppression.

A3B5 can reduce skin pigmentation and slow melanoma growth.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Finasteride and dutasteride are equally effective and safe for treating BPH.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Canakinumab's effect on COVID-19 outcomes is unclear.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.